Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective doses of ciprofol for laryngeal mask airway insertion combined with fentanyl in children
ChiCTR2500095976Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jan 2025
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in None (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Effective dose of ciprofol for laryngeal mask airway insertion combined with fentanyl in children. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2500095976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095976.